Connect Biopharma (CNTB) IPO Opens 15% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Wells Fargo raises oil price targets citing ongoing supply risks
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
Connect Biopharma Holdings Ltd. (CNTB) Prices 11.25M ADS IPO at $17/ADS
March 19, 2021 6:14 AM EDTConnect Biopharma Holdings Limited (NASDAQ: CNTB) today announced the pricing of its initial public offering of 11,250,000 American Depositary Shares (ADSs), representing 11,250,000 ordinary shares of the Company, at a public offering price of US$17.00 per ADS.
All of the ADSs are being offered by the Company. The Company has granted the... More
